This is in contrast to observations by Koska et al [13], who observed an impaired exenatide-induced increase in digital reactive hyperaemia with systemic blockade of the GLP-1R with exendin-(9,39) in participants with impaired glucose tolerance or diet-controlled diabetes. Here, GLP1R is linked to Impaired glucose tolerance.